Nektar Therapeutics Stock Performance
as on October 20, 2026 at 6:59 am IST
Day's Low
Day's High
$35.75$36.79
2.24%
Downside
0.60%
Upside
52 Week's Low
52 Week's High
$33.40$109.008.67%
Downside
198.06%
Upside
Nektar Therapeutics share price movements today
- Previous Close
- $35.78
- Open
- $35.86
- Volume
- 541.6K
- Market Cap
- $1.2B
- Day's Low - High
- $35.75 - $36.79
- 52 Week Low - High
- $33.40 - $109.00
Nektar Therapeutics Historical Returns
- 1 Month Return
- -46.68 %
- 3 Month Return
- -47.58 %
- 1 Year Return
- -38.06 %
- 3 Year Return
- + 341.73 %
- 5 Year Return
- -85.68 %
Nektar Therapeutics Stock Fundamentals & Key Indicators
Check Nektar Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
-6.7
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-5.63
Industry PE ratio
-7.03
PEG Ratio
-0.59
EBITDA
-134.2M
Revenue (TTM)
54.6M
Profit Margin
99.36%
Return On Equity TTM
-37.99%
Nektar Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Nektar Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $1.2B | -85.68% | -5.63 | 99.36% | 0.00% | |
| Neutral | $87.0B | -34.65% | -29.64 | -12.57% | 0.00% | |
| StrongBuy | $126.7B | 169.53% | 28.85 | 86.04% | 0.00% | |
| Buy | $81.4B | 43.22% | 19.01 | 84.86% | 0.47% |
Stock Returns calculator for Nektar Therapeutics Stock including INR - Dollar returns
The Nektar Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Nektar Therapeutics investment value today
Current value as on today
₹68,374
Returns
Returns from Nektar Therapeutics Stock
Dollar Impact
₹5,071 (+5.07%)
Analyst Recommendation on Nektar Therapeutics Stock
Based on 8 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Nektar Therapeutics. Average target price of $133.08
Nektar Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Nektar Therapeutics.
What analysts predicted
72.52%UPSIDE
Target Price
$133.08
Current Price
$36.57
Analyzed by
8 Analysts
High
$192
Target
$133.08
Low
$50
Nektar Therapeutics target price $133.08, a slight upside of 72.52% compared to current price of $36.57. According to 8 analysts rating.
Indian Investors' Interest in Nektar Therapeutics Stock
Search interest for Nektar Therapeutics Stock has increased by 44% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:44% versus previous 30 day period
Nektar Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Nektar Therapeutics Annual Profit & Loss
All numbers in Millions USD
Nektar Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Nektar Therapeutics Annual Cash Flow
All numbers in Millions USD
Nektar Therapeutics News & Key Events
Today's Timeline - 01 October
Thu, 05:10 PM
-Nektar presents long-term data on rezpegaldesleukin, showing efficacy in alopecia areata and atopic dermatitis at EADV Congress.
Thu, 07:35 PM
-Nektar shares fall 19.8% after rezpegaldesleukin data release, despite showing efficacy in alopecia and atopic dermatitis.
Thu, 09:45 PM
-William Blair maintains Outperform rating on Nektar, citing durability advantage of rezpegaldesleukin over standard treatments.
Today's Timeline - 01 October
Thu, 11:55 PM
-Jefferies analyst calls Nektar's selloff unwarranted, maintains Buy rating and $150 price target.
Fri, 01:12 AM
-Nektar shares drop 21% despite positive rezpegaldesleukin data; ongoing legal issues with Eli Lilly remain unresolved.
Insights on Nektar Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, -44.90M → -40.62M (in $), with an average increase of 10.5% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, NKTR has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 776.3%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 3 quarters, 21.80M → 10.13M (in $), with an average decrease of 28.5% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, NKTR stock has moved down by -46.7%
About Nektar Therapeutics
| Organisation | Nektar Therapeutics |
| Headquarters | 455 Mission Bay Boulevard South, San Francisco, CA, 94158, US |
| Industry | Biotechnology |
| CEO | Howard W. Robin |
Key Management of Nektar Therapeutics
Name | Title |
|---|---|
Ms. Elizabeth Zhang | VP of Legal, Corporate Counsel & Secretary |
Mr. Spilios Asimakopoulos | Vice President of Commercial Strategy & Marketing |
Dr. Mary Tagliaferri L.Ac., M.D. | Chief Medical Officer |
Ms. Linda M. Rubinstein M.A. | CFO and Principal Financial & Accounting Officer |
Mr. Jason Barnard | Chief Accounting Officer |
Mr. Robert Bacci | Chief People Officer and Head of Quality & Facilities |
Ms. Jennifer Ruddock | Chief Business Officer |
Dr. Ken Franke Ph.D. | Senior Vice President of Biologics Process Development & Manufacturing |
Mr. Howard W. Robin | CEO, President & Director |
Dr. Jonathan Zalevsky Ph.D. | Senior VP and Chief Research & Development Officer |
FAQs
What is Nektar Therapeutics share price today?
Nektar Therapeutics share price today is $36.57 as on at the close of the market. Nektar Therapeutics share today touched a day high of $36.79 and a low of $35.75.
What is the 52 week high and 52 week low for Nektar Therapeutics share?
Nektar Therapeutics share touched a 52 week high of $109.00 on and a 52 week low of $33.40 on . Nektar Therapeutics stock price today i.e. is closed at $36.57,which is 66.45% down from its 52 week high and 9.49% up from its 52 week low.
What is Nektar Therapeutics's market capitalisation today?
Nektar Therapeutics market capitalisation is $0.00T as on .
How to invest in Nektar Therapeutics Stock (NKTR) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Nektar Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Nektar Therapeutics Stock (NKTR) from India?
Indian investors can start investing in Nektar Therapeutics (NKTR) shares with as little as ₹94.91500091552734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.15 in Nektar Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Nektar Therapeutics share’s latest price of $36.57 as on October 20, 2026 at 1:29 am IST, you will get 0.2734 shares of Nektar Therapeutics. Learn more about
fractional shares .
What are the returns that Nektar Therapeutics has given to Indian investors in the last 5 years?
Nektar Therapeutics stock has given -85.68% share price returns and 26.42% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?